2013 -- H 5063 SUBSTITUTE A

=======

LC00046/SUB A/2

=======

STATE OF RHODE ISLAND

IN GENERAL ASSEMBLY

JANUARY SESSION, A.D. 2013

____________

A N A C T

RELATING TO FOOD AND DRUGS - UNIFORM CONTROLLED SUBSTANCE ACT

     Introduced By: Representatives Corvese, McNamara, O'Brien, Azzinaro, and Malik

     Date Introduced: January 10, 2013

     Referred To: House Judiciary

It is enacted by the General Assembly as follows:

1-1

     SECTION 1. Section 21-28-2.0.8 of the General Laws in Chapter 21-28 entitled

1-2

"Uniform Controlled Substances Act" is hereby amended to read as follows:

1-3

     21-28-2.08. Contents of schedules. -- Schedule I

1-4

      (a) Schedule I shall consist of the drugs and other substances, by whatever official name,

1-5

common or usual name, chemical name, or brand name designated, listed in this section.

1-6

      (b) Opiates. - Unless specifically excepted or unless listed in another schedule, any of

1-7

the following opiates, including its isomers, esters, ethers, salts, and salts of isomers, esters, and

1-8

ethers whenever the existence of the isomers, esters, ethers, and salts is possible within the

1-9

specific chemical designation:

1-10

      (1) Acetylmethadol

1-11

      (2) Allylprodine

1-12

      (3) Alphacetylmethadol

1-13

      (4) Alphameprodine

1-14

      (5) Alphamethadol

1-15

      (6) Benzethidine

1-16

      (7) Betacetylmethadol

1-17

      (8) Betameprodine

1-18

      (9) Betamethadol

1-19

      (10) Betaprodine

2-20

      (11) Clonitazene

2-21

      (12) Dextromoramide

2-22

      (13) Difenoxin

2-23

      (14) Diampromide

2-24

      (15) Diethylthiambutene

2-25

      (16) Dimenoxadol

2-26

      (17) Dimepheptanol

2-27

      (18) Dimethylthiambutene

2-28

      (19) Dioxaphetyl butyrate

2-29

      (20) Dipipanone

2-30

      (21) Ethylmethylthiambutene

2-31

      (22) Etonitazene

2-32

      (23) Extoxerdine

2-33

      (24) Furethidine

2-34

      (25) Hydroxypethidine

2-35

      (26) Ketobemidone

2-36

      (27) Levomoramide

2-37

      (28) Levophenacylmorphan

2-38

      (29) Morpheridine

2-39

      (30) Noracymethadol

2-40

      (31) Norlevorphanol

2-41

      (32) Normethadone

2-42

      (33) Norpipanone

2-43

      (34) Phenadoxone

2-44

      (35) Phenampromide

2-45

      (36) Phenomorphan

2-46

      (37) Phenoperidine

2-47

      (38) Piritramide

2-48

      (39) Proheptazine

2-49

      (40) Properidine

2-50

      (41) Propiram

2-51

      (42) Racemoramide

2-52

      (43) Trimeperidone

2-53

      (44) Tilidine

3-54

      (45) Alpha-methylfentanyl

3-55

      (46) Beta-hydroxy-3-methylfentanyl other names:

3-56

      N-[1-(2hydroxy-2-phenethyl)-3-methyl-4piperidingyl] Nphenylpropanamide

3-57

      (c) Opium Derivatives. - Unless specifically excepted or unless listed in another

3-58

schedule, any of the following opium derivatives, its salts, isomers, and salts of isomers whenever

3-59

the existence of the salts, isomers, and salts of isomers is possible within the specific chemical

3-60

designation:

3-61

      (1) Acetorphine

3-62

      (2) Acetyldihydrocodeine

3-63

      (3) Benzylmorphine

3-64

      (4) Codeine methylbromide

3-65

      (5) Codeine-N-Oxide

3-66

      (6) Cyprenorphine

3-67

      (7) Desomorphine

3-68

      (8) Dihydromorphine

3-69

      (9) Etorphine (Except hydrochloride salt)

3-70

      (10) Heroin

3-71

      (11) Hydromorphinol

3-72

      (12) Methyldesorphine

3-73

      (13) Methylihydromorphine

3-74

      (14) Morphine methylbromide

3-75

      (15) Morphine methylsulfonate

3-76

      (16) Morphine-N-Oxide

3-77

      (17) Myrophine

3-78

      (18) Nococodeine

3-79

      (19) Nicomorphine

3-80

      (20) Normorphine

3-81

      (21) Pholcodine

3-82

      (22) Thebacon

3-83

      (23) Drotebanol

3-84

      (d) Hallucinogenic Substances. - Unless specifically excepted or unless listed in another

3-85

schedule, any material, compound, mixture, or preparation, which contains any quantity of the

3-86

following hallucinogenic substances, or which contains any of its salts, isomers, and salts of

3-87

isomers whenever the existence of the salts, isomers, and salts of isomers is possible within the

3-88

specific chemical designation (for purposes of this subsection only, the term "isomer" includes

4-1

the optical, position, and geometric isomers):

4-2

      (1) 3, 4-methylenedioxy amphetamine

4-3

      (2) 5-methoxy-3, 4-methylenedioxy amphetamine

4-4

      (3) 3, 4, 5-trimethoxy amphetamine

4-5

      (4) Bufotenine

4-6

      (5) Diethyltryptamine

4-7

      (6) Dimethyltryptamine

4-8

      (7) 4-methyl 2, 5-dimethoxyamphetamine

4-9

      (8) Ibogaine

4-10

      (9) Lysergic acid diethylamide

4-11

      (10) Marihuana

4-12

      (11) Mescaline

4-13

      (12) Peyote. Meaning all parts of the plant presently classified botanically as

4-14

Lophophora Williamsii Lemair whether growing or not; the seeds of the plant; any extract from

4-15

any part of the plant; and any compound, manufacture, salt, derivative, mixture, or preparation of

4-16

the plant, its seeds or extracts.

4-17

      (13) N-ethyl-3-piperidyl benzilate

4-18

      (14) N-methyl-3-piperidyl benzilate

4-19

      (15) Psilocybin

4-20

      (16) Psilocyn

4-21

      (17) Tetrahydrocannabinols. Synthetic equivalents of the substances contained in the

4-22

plant, or in the resinous extractives of Cannabis, sp. and/or synthetic substances, derivatives, and

4-23

their isomers with similar chemical structure and pharmacological activity such as the following:

4-24

delta 1 cis or trans tetrahydrocannabinol, and their optical isomers. Delta 6 cis or trans

4-25

tetrahydrocannabinol and their optical isomers. Delta 3, 4 cis or trans tetrahydrocannabinol and

4-26

its optical isomer. (Since nomenclature of these substances is not internationally standardized,

4-27

compounds of these structures, regardless of numerical designation of atomic positions covered).

4-28

      (18) Thiophene analog of phencyclidine. 1-(1-(2 thienyl) cyclo-hexyl) pipiridine: 2-

4-29

Thienyl analog of phencyclidine: TPCP

4-30

      (19) 2,5 dimethoxyamphetamine

4-31

      (20) 4-bromo-2,5-dimethoxyamphetamine, 4-bromo-2,5-dimethoxy-alpha-

4-32

methylphenethyamine: 4-bromo-2,5-DMA

4-33

      (21) 4-methoxyamphetamine-4-methoxy-alpha-methylphenethylaimine:

4-34

paramethoxyamphetamine: PMA

5-1

      (22) Ethylamine analog of phencyclidine. N-ethyl-1- phenylcyclohexylamine, (1-

5-2

phenylcyclohexyl) ethylamine, N-(1-phenylcyclophexyl) ethylamine, cyclohexamine, PCE

5-3

      (23) Pyrrolidine analog of phencyclidine. 1-(1-phencyclohexyl)- pyrrolidine PCPy, PHP

5-4

      (24) Parahexyl; some trade or other names: 3-Hexyl-1-hydroxy-7,8,9,10-tetrahydro-

5-5

6,6,9-trimethyl-6H-dibenz o (b,d) pyran: Synhexyl.

5-6

     (25) Salvia Divinorum (Salvinorin A or Divinorin A), meaning any extract from any part

5-7

of the plant; and any compound, salt derivative, or mixture of the plant or its extracts. This shall

5-8

not mean the unaltered plant.

5-9

     (26) Datura stamonium (jimsom weed or datura), meaning any extract from any part of

5-10

the plant; and any compound, salt derivative, or mixture of the plant or its extracts. This shall not

5-11

mean the unaltered plant.

5-12

      (e) Depressants. - Unless specifically excepted or unless listed in another schedule, any

5-13

material, compound, mixture, or preparation which contains any quantity of the following

5-14

substances having a depressant effect on the central nervous system, including its salts, isomers,

5-15

and salts of isomers whenever the existence of the salts, isomers, and salts of isomers is possible

5-16

within the specific chemical designation:

5-17

      (1) Mecloqualone.

5-18

      (2) Methaqualone.

5-19

      (3) 3-methyl fentanyl (n-( ethyl-1(2-phenylethyl)-4-piperidyl)-N-phenylpropanamide.

5-20

      (4) 3,4-methyl-enedioxymethamphetamine (MDMA), its optical, positional and

5-21

geometric isomers, salts, and salts of isomers.

5-22

      (5) 1-methyl-4-phenyl-4-propionoxypiperidine (MPPP), its optical isomers, salts and

5-23

salts of isomers.

5-24

      (6) 1-(2-phenylethyl)-4-phenyl-4-acetyloxypiperidine (PEPAP), its optical isomers, salts

5-25

and salts of isomers.

5-26

      (7) N-(1-(1-methyl-2-phenyl)ethyl-4-piperidyl)-N-phenyl-acetamide (acetyl-alpha-

5-27

methylfentanyl), its optical isomers, salts and salts of isomers.

5-28

      (8) N-(1-(1-methyl-2(2-thienyl)ethyl-4-piperidyl)-N-phenylpropanami de (alpha-

5-29

methylthiofentanyl), its optical isomers, salts and salts of isomers.

5-30

      (9) N-(1-benzyl-piperidyl)-N-phenylpropanamide (benzyl-fentanyl), its optical isomers,

5-31

salts and salts of isomers.

5-32

      (10) N-(1-(2-hydroxy-2-phenyl)ethyl-4-piperidyl)-N-phenyl-propanamid e (beta-

5-33

hydroxyfentanyl), its optical isomers, salts and salts of isomers.

6-34

      (11) N-(3-methyl-1(2-hydroxy-2-phenyl)ethyl-4-piperidyl)-N-phenylpro panamide (beta-

6-35

hydroxy-3-methylfentanyl), its optical and geometric isomers, salts and salts of isomers.

6-36

      (12) N-(3-methyl)-1-(2-(2-thienyl)ethyl-4-piperidyl)-N-phenylpro- panamide (3-

6-37

methylthiofentanyl), its optical and geometric isomers, salts and salts of isomers.

6-38

      (13) N-(1-2-thienyl)methyl-4-piperidyl)-N-phenylpropanamide (thenylfentanyl), its

6-39

optical isomers, salts and salts of isomers.

6-40

      (14) N-(1-(2(2-thienyl)ethyl-4-piperidyl-N-phenylpropanamide (thiofentanyl), its optical

6-41

isomers, salts and salts of isomers.

6-42

      (15) N-[1-(2-phenylethyl)-4-piperidyl]N-(4-fluorophenyl)-propanamid e (para-

6-43

fluorofentanyl), its optical isomers, salts and salts of isomers.

6-44

      (16) Gamma hydroxybutyrate, HOOC-CH2-CH2-CH2OH, its optical, position, or

6-45

geometric isomers, salts and salts of isomers.

6-46

     (f) Stimulants. - Unless specifically excepted or unless listed in another schedule, any

6-47

material, compound, mixture, or preparation which contains any quantity of the following

6-48

substances having a stimulant effect on the central nervous system, including its salts, isomers,

6-49

and salts of isomers:

6-50

      (1) Fenethylline

6-51

      (2) N-ethylamphetamine

6-52

      (3) 4-methyl-N-methylcathinone (Other name: mephedrone)

6-53

      (4) 3,4-methylenedioxy-N-methlycathinone (Other name: methylone)

6-54

      (5) 3,4-methylenedioxypyrovalerone (Other name: MDPV)

6-55

      (g) Any material, compound, mixture or preparation which contains any quantity of the

6-56

following substances:

6-57

      (1) 5-(1,1-Dimethylheptyl)-2-[(1R,3S)-3-hydroxycyclohexyl]phenol (CP-47,497)

6-58

      (2) 5-(1,1-Dimethyloctyl)-2-[(1R,3S)-3-hydroxycyclohexyl]phenol

6-59

(cannabicyclohexanol and CP-47,497 c8 homologue)

6-60

      (3) 1-Butyl-3-(1 naphthoyl)indole, (JWH-073)

6-61

      (4) 1-[2-(4-Morpholinyl)ethyl]3-(1-naphthoyl)indole (JWH-200)

6-62

      (5) 1-Pentyl-3-(1-napthoyl)indole, (JWH-018 and AM678)

6-63

      Schedule II

6-64

      (a) Schedule II shall consist of the drugs and other substances, by whatever official

6-65

name, common or usual name, chemical name, or brand name designated, listed in this section.

6-66

      (b) Substances, vegetable origin or chemical synthesis. - Unless specifically excepted or

6-67

unless listed in another schedule, any of the following substances whether produced directly or

6-68

indirectly by extraction from substances of vegetable origin, or independently by means of

7-1

chemical synthesis, or by a combination of extraction and chemical synthesis:

7-2

      (1) Opium and opiate, and any salt, compound, derivative, or preparation of opium or

7-3

opiate excluding naloxone and its salts, and excluding naltrexone and its salts, but including the

7-4

following:

7-5

      (i) Raw opium

7-6

      (ii) Opium extracts

7-7

      (iii) Opium fluid extracts

7-8

      (iv) Powdered opium

7-9

      (v) Granulated opium

7-10

      (vi) Tincture of opium

7-11

      (vii) Etorphine hydrochloride

7-12

      (viii) Codeine

7-13

      (ix) Ethylmorphine

7-14

      (x) Hydrocodone

7-15

      (xi) Hydromorphone

7-16

      (xii) Metopon

7-17

      (xiii) Morphine

7-18

      (xiv) Oxycodone

7-19

      (xv) Oxymorphone

7-20

      (xvi) Thebaine

7-21

      (2) Any salt, compound, derivative, or preparation which is chemically equivalent or

7-22

identical with any of the substances referred to in subdivision (1) of this subsection, except that

7-23

these substances shall not include the isoquinoline alkaloids of opium.

7-24

      (3) Opium poppy and poppy straw.

7-25

      (4) Coca leaves and any salt, compound, derivative, or preparation of coca leaves, and

7-26

any salt, compound, derivative, or preparation which is chemically equivalent or identical with

7-27

any of these substances, except that the substances shall not include decocainized coca leaves or

7-28

extraction of coca leaves, which extractions do not contain cocaine or ecgonine.

7-29

      (5) Concentrate of poppy straw (the crude extract of poppy straw in liquid, solid, or

7-30

powder form which contains the phenanthrine alkaloids of the opium poppy).

7-31

      (c) Opiates. - Unless specifically excepted or unless listed in another schedule any of the

7-32

following opiates, including its isomers, esters, ethers, salts; and salts of isomers, esters and,

7-33

ethers whenever the existence of the isomers, esters, ethers, and salts is possible within the

7-34

specific chemical designation:

8-1

      (1) Alphaprodine

8-2

      (2) Anileridine

8-3

      (3) Bezitramide

8-4

      (4) Dihydrocodeine

8-5

      (5) Diphenoxylate

8-6

      (6) Fentanyl

8-7

      (7) Isomethadone

8-8

      (8) Levomethorphan

8-9

      (9) Levorphanol

8-10

      (10) Metazocine

8-11

      (11) Methadone

8-12

      (12) Methadone-Intermediate, 4-cyano-2-dimethylamino-4, 4-diphenyl butane

8-13

      (13) Moramide-Intermediate, 2-methyl-3-morpholino-1, 1-diphenylpropane-carboxylic

8-14

acid

8-15

      (14) Pethidine

8-16

      (15) Pethidine-Intermediate-A, 4-cyano-1-methyl-4-phenylpiperidine

8-17

      (16) Pethidine-Intermediate-B, ethyl-4-phenylpiperidine-4-carboxylate

8-18

      (17) Pethidine-Intermediate-C, 1-methyl-4-phenylpiperidine-4-carboxylic acid

8-19

      (18) Phenaxocine

8-20

      (19) Piminodine

8-21

      (20) Racemethorphan

8-22

      (21) Racemorphan

8-23

      (22) Bulk Dextropropoxyphene (non-dosage forms)

8-24

      (23) Suffentanil

8-25

      (24) Alfentanil

8-26

      (25) Levoalphacetylmethadol

8-27

      (d) Stimulants. - Unless specifically excepted or unless listed in another schedule, any

8-28

material, compound, mixture, or preparation which contains any quantity of the following

8-29

substances having a stimulant effect on the central nervous system:

8-30

      (1) Amphetamine, its salts, optical isomers, and salts of its optical isomers.

8-31

      (2) Methamphetamine, its salts and salts of its isomers.

8-32

      (3) Phenmetrazine and its salts.

8-33

      (4) Methylphenidate.

9-34

      (e) Depressants. - Unless specifically excepted or unless listed in another schedule, any

9-35

material, compound, mixture, or preparation which contains any quantity of the following

9-36

substances having a depressant effect on the central nervous system, including its salts, isomers,

9-37

and salts of isomers whenever the existence of the salts, isomers, and salts of isomers is possible

9-38

within the specific chemical designation:

9-39

      (1) Amobarbital

9-40

      (2) Glutethimide

9-41

      (3) Methyprylon

9-42

      (4) Pentobarbital

9-43

      (5) Phencyclidine

9-44

      (6) Secobarbital

9-45

      (7) Phencyclidine immediate precursors:

9-46

      (i) 1-phencyclohexylamine

9-47

      (ii) 1-piperidinocyclohexane-carbonitrile (PCC)

9-48

      (8) Immediate precursor to amphetamine and methamphetamine: Phenylacetone. Some

9-49

other names: phenyl-2-propanone; P2P; benzyl methyl ketone; methyl benzone ketone.

9-50

      Schedule III

9-51

      (a) Unless specifically excepted or unless listed in another schedule, any material,

9-52

compound, mixture, or preparation which contains any quantity of the following substances

9-53

having a depressant effect on the central nervous system:

9-54

      (1) Any substance which contains any quantity of a derivative of barbituric acid, or any

9-55

salt of a derivative of barbituric acid.

9-56

      (2) Chlorhexadol

9-57

      (3) Lysergic acid

9-58

      (4) Lysergic acid amide

9-59

      (5) Sulfondiethylmethane

9-60

      (6) Sulfonethylmethane

9-61

      (7) Sylfonmethane

9-62

      (8) Any compound, mixture, or preparation containing amobarbital, secobarbital,

9-63

pentobarbital, or any salt of them and one or more other active medicinal ingredients which are

9-64

not listed in any schedule.

9-65

      (9) Any suppository dosage form containing amobarbital, secobarbital, pentobarbital or

9-66

any salt of any of these drugs and approved by the Food and Drug Administration for marketing

9-67

only as a suppository.

10-68

      (10) Ketamine, its salts, isomers and salts of isomers. (Some other names for ketamine:

10-69

(+)-2-(2-chlorophenyl)-2-(methylamino)-cyclohexanone).

10-70

      (b) Unless specifically excepted or unless listed in another schedule, any material,

10-71

compound, mixture, or preparation containing limited quantities of any of the following narcotic

10-72

drugs, or any salts of them:

10-73

      (1) Not more than one and eight tenths grams (1.8 gms.) of codeine per one hundred

10-74

milliliters (100 mls.) or not more than ninety milligrams (90 mgs.) per dosage unit, with an equal

10-75

or greater quantity of an isoquinoline alkaloid of opium.

10-76

      (2) Not more than one and eight tenths grams (1.8 gms.) of codeine per one hundred

10-77

milliliters (100 mls.) or not more than ninety milligrams (90 mgs.) per dosage unit, with one or

10-78

more active, nonnarcotic ingredients in recognized therapeutic amounts.

10-79

      (3) Not more than three hundred milligrams (300 mgs.) of dihydrocodeinone per one

10-80

hundred milliliters (100 mls.) or not more than fifteen milligrams (15 mgs.) per dosage unit, with

10-81

a fourfold or greater quantity of an isoquinoline alkaloid of opium.

10-82

      (4) Not more than three hundred milligrams (300 mgs.) of dihydrocodeinone per one

10-83

hundred milliliters (100 mls.) or not more than fifteen milligrams (15 mgs.) per dosage unit, with

10-84

one or more active nonnarcotic ingredients in recognized therapeutic amounts.

10-85

      (5) Not more than one and eight tenths grams (1.8 gms.) of dihydrocodeine per one

10-86

hundred milliliters (100 mls.) or not more than ninety milligrams (90 mgs.) per dosage unit, with

10-87

one or more active nonnarcotic ingredients in recognized therapeutic amounts.

10-88

      (6) Not more than three hundred milligrams (300 mgs.) of ethylmorphine per one

10-89

hundred milliliters (100 mls.) or not more than fifteen milligrams (15 mgs.) per dosage unit, with

10-90

one or more active nonnarcotic ingredients in recognized therapeutic amounts.

10-91

      (7) Not more than five hundred milligrams (500 mgs.) of opium per one hundred

10-92

milliliters (100 mls.) or per one hundred grams (100 gms.) or not more than twenty-five

10-93

milligrams (25 mgs.) per dosage unit, with one or more active nonnarcotic ingredients in

10-94

recognized therapeutic amounts.

10-95

      (8) Not more than fifty milligrams (50 mgs.) of morphine per one hundred milliliters

10-96

(100 mls.) per one hundred grams (100 gms.) with one or more active, nonnarcotic ingredients in

10-97

recognized therapeutic amounts.

10-98

      (c) Stimulants. - Unless specifically excepted or listed in another schedule, any material,

10-99

compound, mixture, or preparation which contains any quantity of the following substances

10-100

having a stimulant effect on the central nervous system, including its salts, isomers, and salts of

10-101

the isomers whenever the existence of the salts of isomers is possible within the specific chemical

10-102

designation:

11-1

      (1) Benzphetamine

11-2

      (2) Chlorphentermine

11-3

      (3) Clortermine

11-4

      (4) Mazindol

11-5

      (5) Phendimetrazine

11-6

      (d) Steroids and hormones. - Anabolic steroids (AS) or human growth hormone (HGH),

11-7

excluding those compounds, mixtures, or preparations containing an anabolic steroid that because

11-8

of its concentration, preparation, mixture or delivery system, has no significant potential for

11-9

abuse, as published in 21 CFR 1308.34, including, but not limited to, the following:

11-10

      (1) Chlorionic gonadotropin

11-11

      (2) Clostebol

11-12

      (3) Dehydrochlormethyltestosterone

11-13

      (4) Ethylestrenol

11-14

      (5) Fluoxymesterone

11-15

      (6) Mesterolone

11-16

      (7) Metenolone

11-17

      (8) Methandienone

11-18

      (9) Methandrostenolone

11-19

      (10) Methyltestosterone

11-20

      (11) Nandrolone decanoate

11-21

      (12) Nandrolone phenpropionate

11-22

      (13) Norethandrolone

11-23

      (14) Oxandrolone

11-24

      (15) Oxymesterone

11-25

      (16) Oxymetholone

11-26

      (17) Stanozolol

11-27

      (18) Testosterone propionate

11-28

      (19) Testosterone-like related compounds

11-29

      (20) Human Growth Hormone (HGH)

11-30

      (e) Hallucinogenic substances.

11-31

      (1) Dronabinol (synthetic) in sesame oil and encapsulated in a soft gelatin capsule in

11-32

U.S. Food and Drug Administration approved drug product. (Some other names for dronabinol:

11-33

(6aR-trans)-6a, 7, 8, 10a- tetrahydro-6, 6, 9- trimethyl-3-pentyl-6H- dibenzo[b,d]yra n-1-ol,or(-)-

11-34

delta-9(trans)-tetrahydrocannabinol.)

12-1

      Schedule IV

12-2

      (1) Barbital.

12-3

      (2) Chloral betaine

12-4

      (3) Chloral hydrate

12-5

      (4) Ethchrovynol

12-6

      (5) Ethinamate

12-7

      (6) Methohexital

12-8

      (7) Meprobamate

12-9

      (8) Methylphenobarbital

12-10

      (9) Paraldehyde

12-11

      (10) Petrichloral

12-12

      (11) Phenobarbital

12-13

      (12) Fenfluramine

12-14

      (13) Diethylpropion

12-15

      (14) Phentermine

12-16

      (15) Pemoline (including organometallic complexes and chelates thereof).

12-17

      (16) Chlordiazepoxide

12-18

      (17) Clonazepam

12-19

      (18) Clorazepate

12-20

      (19) Diazepam

12-21

      (20) Flurazepam

12-22

      (21) Mebutamate

12-23

      (22) Oxazepam

12-24

      (23) Unless specifically excepted or unless listed in another schedule, any material,

12-25

compound, mixture, or preparation which contains any quantity of the following substances,

12-26

including its salts:

12-27

      Dextropropoxyphene(alpha-(+)-4-dimethylamino-1,2-diphenyl-3- methyl-2-

12-28

propronoxybutane).

12-29

      (24) Prazepam

12-30

      (25) Lorazepam

12-31

      (26) Not more than one milligram (1 mg.) of difenoxin and not less than twenty-five (25)

12-32

micrograms of atropine sulfate per dosage unit.

12-33

      (27) Pentazocine

13-34

      (28) Pipradrol

13-35

      (29) SPA (-)-1-dimethylamino-1, 2-diphenylethane

13-36

      (30) Temazepam

13-37

      (31) Halazepam

13-38

      (32) Alprazolam

13-39

      (33) Bromazepam

13-40

      (34) Camazepam

13-41

      (35) Clobazam

13-42

      (36) Clotiazepam

13-43

      (37) Cloxazolam

13-44

      (38) Delorazepam

13-45

      (39) Estazolam

13-46

      (40) Ethyl Ioflazepate

13-47

      (41) Fludizaepam

13-48

      (42) Flunitrazepam

13-49

      (43) Haloxazolam

13-50

      (44) Ketazolam

13-51

      (45) Loprazolam

13-52

      (46) Lormetazepam

13-53

      (47) Medazepam

13-54

      (48) Nimetazepam

13-55

      (49) Nitrazepam

13-56

      (50) Nordiazepam

13-57

      (51) Oxazolam

13-58

      (52) Pinazepam

13-59

      (53) Tetrazepam

13-60

      (54) Mazindol

13-61

      (55) Triazolam

13-62

      (56) Midazolam

13-63

      (57) Quazepam

13-64

      (58) Butorphanol

13-65

      (59) Sibutramine

13-66

      Schedule V

13-67

      (a) Any compound, mixture, or preparation containing any of the following limited

13-68

quantities of narcotic drugs, which shall include one or more non-narcotic active medicinal

14-1

ingredients in sufficient proportion to confer upon the compound, mixture, or preparation

14-2

valuable medicinal qualities other than those possessed by the narcotic drug alone:

14-3

      (1) Not more than two hundred milligrams (200 mgs.) of codeine per 100 milliliters (100

14-4

mls.) or per one hundred grams (100 gms.).

14-5

      (2) Not more than one hundred milligrams (100 mgs.) of dihydrocodeine per 100

14-6

milliliters (100 mls.) or per one hundred grams (100 gms.).

14-7

      (3) Not more than one hundred milligrams (100 mgs.) of ethylmorphine per 100

14-8

milliliters (100 mls.) or per one hundred grams (100 gms.).

14-9

      (4) Not more than two and five tenths milligrams (2.5 mgs.) of diphenixylate and not less

14-10

than twenty-five (25) micrograms of atropine sulfate per dosage unit.

14-11

      (5) Not more than one hundred milligrams (100 mgs.) of opium per one hundred

14-12

milliliters (100 mls.) or per one hundred grams (100 gms.).

14-13

      (b) Not more than five tenths milligrams (0.5 mgs.) of difenoxin and not less than

14-14

twenty-five (25) micrograms of atropine sulfate per dosage unit.

14-15

      (c) Buprenorphine

14-16

      (d) Unless specifically exempted or excluded or unless listed in another schedule, any

14-17

material, compound, mixture, or preparation which contains any quantity of the following

14-18

substances having a stimulant effect on the central nervous system, including its salts, isomers

14-19

and salts of isomers:

14-20

      (1) Propylhexedrine (except as benzedrex inhaler)

14-21

      (2) Pyrovalerone.

14-22

     SECTION 2. Section 21-28-4.0.1 of the General Laws in Chapter 21-28 entitled

14-23

"Uniform Controlled Substances Act" is hereby amended to read as follows:

14-24

     21-28-4.01. Prohibited acts A -- Penalties. [Effective April 1, 2013.] -- (a) (1) Except

14-25

as authorized by this chapter, it shall be unlawful for any person to manufacture, deliver, or

14-26

possess with intent to manufacture or deliver a controlled substance.

14-27

      (2) Any person who is not a drug addicted person, as defined in section 21-28-1.02(18),

14-28

who violates this subsection with respect to a controlled substance classified in schedule I or II,

14-29

except the substance classified as marijuana, is guilty of a crime and upon conviction may be

14-30

imprisoned to a term up to life, or fined not more than five hundred thousand dollars ($500,000)

14-31

nor less than ten thousand dollars ($10,000), or both.

14-32

      (3) Where the deliverance as prohibited in this subsection shall be the proximate cause of

14-33

death to the person to whom the controlled substance is delivered, it shall not be a defense that

14-34

the person delivering the substance was at the time of delivery, a drug addicted person as defined

15-1

in section 21-28-1.02(18).

15-2

      (4) Any person, except as provided for in subdivision (2) of this subsection, who violates

15-3

this subsection with respect to:

15-4

      (i) A controlled substance classified in schedule I or II, is guilty of a crime and upon

15-5

conviction may be imprisoned for not more than thirty (30) years, or fined not more than one

15-6

hundred thousand dollars ($100,000) nor less than three thousand dollars ($3,000), or both;

15-7

      (ii) A controlled substance classified in schedule III or IV, is guilty of a crime and upon

15-8

conviction may be imprisoned for not more than twenty (20) years, or fined not more than forty

15-9

thousand dollars ($40,000), or both; provided, with respect to a controlled substance classified in

15-10

schedule III(d), upon conviction may be imprisoned for not more than five (5) years, or fined not

15-11

more than twenty thousand dollars ($20,000), or both.

15-12

      (iii) A controlled substance classified in schedule V, is guilty of a crime and upon

15-13

conviction may be imprisoned for not more than one year, or fined not more than ten thousand

15-14

dollars ($10,000), or both.

15-15

      (b) (1) Except as authorized by this chapter, it is unlawful for any person to create,

15-16

deliver, or possess with intent to deliver, a counterfeit substance.

15-17

      (2) Any person who violates this subsection with respect to:

15-18

      (i) A counterfeit substance classified in schedule I or II, is guilty of a crime and upon

15-19

conviction may be imprisoned for not more than thirty (30) years, or fined not more than one

15-20

hundred thousand dollars ($100,000), or both;

15-21

      (ii) A counterfeit substance classified in schedule III or IV, is guilty of a crime and upon

15-22

conviction may be imprisoned for not more than twenty (20) years, or fined not more than forty

15-23

thousand dollars ($40,000), or both; provided, with respect to a controlled substance classified in

15-24

schedule III(d), upon conviction may be imprisoned for not more than five (5) years, or fined not

15-25

more than twenty thousand dollars ($20,000) or both.

15-26

      (iii) A counterfeit substance classified in schedule V, is guilty of a crime and upon

15-27

conviction may be imprisoned for not more than one year, or fined not more than ten thousand

15-28

dollars ($10,000), or both.

15-29

      (c) (1) It shall be unlawful for any person knowingly or intentionally to possess a

15-30

controlled substance, unless the substance was obtained directly from or pursuant to a valid

15-31

prescription or order of a practitioner while acting in the course of his or her professional

15-32

practice, or except as otherwise authorized by this chapter.

15-33

      (2) Any person who violates this subsection with respect to:

16-34

      (i) A controlled substance classified in schedules I, II and III, IV, and V, except the

16-35

substance classified as marijuana, is guilty of a crime and upon conviction may be imprisoned for

16-36

not more than three (3) years or fined not less than five hundred dollars ($500) nor more than five

16-37

thousand dollars ($5,000), or both;

16-38

      (ii) More than one ounce (1 oz.) of a controlled substance classified in schedule I as

16-39

marijuana is guilty of a misdemeanor except for those persons subject to subdivision 21-28-

16-40

4.01(a)(1) and upon conviction may be imprisoned for not more than one year or fined not less

16-41

than two hundred dollars ($200) nor more than five hundred dollars ($500), or both.

16-42

      (iii) Notwithstanding any public, special or general law to the contrary, the possession of

16-43

one ounce (1 oz.) or less of marijuana by a person who is eighteen (18) years of age or older and

16-44

who is not exempted from penalties pursuant to chapter 21-28.6 shall constitute a civil offense,

16-45

rendering the offender liable to a civil penalty in the amount of one hundred fifty dollars ($150)

16-46

and forfeiture of the marijuana, but not to any other form of criminal or civil punishment or

16-47

disqualification. Notwithstanding any public, special or general law to the contrary, this civil

16-48

penalty of one hundred fifty dollars ($150) and forfeiture of the marijuana shall apply if the

16-49

offense is the first (1st) or second (2nd) violation within the previous eighteen (18) months.

16-50

      (iv) Notwithstanding any public, special or general law to the contrary, possession of one

16-51

ounce (1 oz.) or less of marijuana by a person who is under the age of eighteen (18) years and

16-52

who is not exempted from penalties pursuant to chapter 21-28.6 shall constitute a civil offense,

16-53

rendering the offender liable to a civil penalty in the amount of one hundred fifty dollars ($150)

16-54

and forfeiture of the marijuana; provided the minor offender completes an approved drug

16-55

awareness program and community service as determined by the court. If the person under the

16-56

age of eighteen (18) years fails to complete an approved drug awareness program and community

16-57

service within one year of the offense, the penalty shall be a three hundred dollar ($300) civil fine

16-58

and forfeiture of the marijuana, except that if no drug awareness program or community service is

16-59

available, the penalty shall be a fine of one hundred fifty dollars ($150) and forfeiture of the

16-60

marijuana. The parents or legal guardian of any offender under the age of eighteen (18) shall be

16-61

notified of the offense and the availability of a drug awareness and community service program.

16-62

The drug awareness program must be approved by the court, but shall, at a minimum, provide

16-63

four (4) hours of instruction or group discussion, and ten (10) hours of community service.

16-64

Notwithstanding any other public, special or general law to the contrary, this civil penalty shall

16-65

apply if the offense is the first (1st) or second (2nd) violation within the previous eighteen (18)

16-66

months.

16-67

      (v) Notwithstanding any public, special, or general law to the contrary, a person not

16-68

exempted from penalties pursuant to chapter 21-28.6 found in possession of one ounce (1 oz.) or

17-1

less of marijuana is guilty of a misdemeanor and upon conviction may be imprisoned for not

17-2

more than thirty (30) days or fined not less than two hundred dollars ($200) nor more than five

17-3

hundred dollars ($500), or both, if that person has been previously adjudicated on a violation for

17-4

possession of less than one ounce (1 oz.) of marijuana under subparagraphs 21-28-4.01(c)(2)(iii)

17-5

or 21-28-4.01(c)(2)(iv) two (2) times in the eighteen (18) months prior to the third (3rd) offense.

17-6

      (vi) Any unpaid civil fine issued under subparagraphs 21-28-4.01(c)(2)(iii) or 21-28-

17-7

4.01(c)(2)(iv) shall double to three hundred dollars ($300) if not paid within thirty (30) days of

17-8

the offense. The civil fine shall double again to six hundred dollars ($600) if it has not been paid

17-9

within ninety (90) days.

17-10

      (vii) No person may be arrested for a violation of subparagraphs 21-28-4.01(c)(2)(iii) or

17-11

21-28-4.01(c)(2)(iv) except as provided in this subparagraph. Any person in possession of an

17-12

identification card, license, or other form of identification issued by the state or any state, city or

17-13

town, or any college or university, who fails to produce the same upon request of a police officer

17-14

who informs the person that he or she has been found in possession of what appears to the officer

17-15

to be one ounce (1 oz.) or less of marijuana, or any person without any such forms of

17-16

identification that fails or refuses to truthfully provide his or her name, address, and date of birth

17-17

to a police officer who has informed such person that the officer intends to provide such

17-18

individual with a citation for possession of one ounce (1 oz.) or less of marijuana, may be

17-19

arrested.

17-20

      (viii) No violation of subparagraphs 21-28-4.01(c)(2)(iii) or 21-28-4.01(c)(2)(iv) shall be

17-21

considered a violation of parole or probation.

17-22

      (ix) Any records collected by any state agency or tribunal that include personally

17-23

identifiable information about violations of subparagraphs 21-28-4.01(c)(2)(iii) or 21-28-

17-24

4.01(c)(2)(iv) shall be sealed eighteen (18) months after the payment of said civil fine.

17-25

      (3) Jurisdiction. - Any and all violations of subparagraphs 21-28-4.01(c)(2)(iii) and 21-

17-26

28-4.01(c)(2)(iv) shall be the exclusive jurisdiction of the Rhode Island traffic tribunal. All

17-27

money associated with the civil fine issued under subparagraphs 21-28-4.01(c)(2)(iii) or 21-28-

17-28

4.01(c)(2)(iv) shall be payable to the Rhode Island traffic tribunal. Fifty percent (50%) of all fines

17-29

collected by the Rhode Island traffic tribunal from civil penalties issued pursuant to

17-30

subparagraphs 21-28-4.01(c)(2)(iii) or 21-28-4.01(c)(2)(iv) shall be expended on drug awareness

17-31

and treatment programs for youth.

17-32

      (4) Additionally every person convicted or who pleads nolo contendere under paragraph

17-33

(2)(i) of this subsection or convicted or who pleads nolo contendere a second or subsequent time

17-34

under paragraph (2)(ii) of this subsection, who is not sentenced to a term of imprisonment to

18-1

serve for the offense, shall be required to:

18-2

      (i) Perform, up to one hundred (100) hours of community service;

18-3

      (ii) Attend and complete a drug counseling and education program as prescribed by the

18-4

director of the department of mental health, retardation and hospitals and pay the sum of four

18-5

hundred dollars ($400) to help defray the costs of this program which shall be deposited as

18-6

general revenues. Failure to attend may result after hearing by the court in jail sentence up to one

18-7

year;

18-8

      (iii) The court shall not suspend any part or all of the imposition of the fee required by

18-9

this subsection, unless the court finds an inability to pay;

18-10

      (iv) If the offense involves the use of any automobile to transport the substance or the

18-11

substance is found within an automobile, then a person convicted or who pleads nolo contendere

18-12

under paragraphs (2)(i) and (ii) of this subsection shall be subject to a loss of license for a period

18-13

of six (6) months for a first offense and one year for each offense after this.

18-14

      (5) All fees assessed and collected pursuant to paragraph (3)(ii) of this subsection shall

18-15

be deposited as general revenues and shall be collected from the person convicted or who pleads

18-16

nolo contendere before any other fines authorized by this chapter.

18-17

      (d) It shall be unlawful for any person to manufacture, distribute, or possess with intent

18-18

to manufacture or distribute, an imitation controlled substance. Any person who violates this

18-19

subsection is guilty of a crime, and upon conviction shall be subject to the same term of

18-20

imprisonment and/or fine as provided by this chapter for the manufacture or distribution of the

18-21

controlled substance which the particular imitation controlled substance forming the basis of the

18-22

prosecution was designed to resemble and/or represented to be; but in no case shall the

18-23

imprisonment be for more than five (5) years nor the fine for more than twenty thousand dollars

18-24

($20,000).

18-25

      (e) It shall be unlawful for a practitioner to prescribe, order, distribute, supply, or sell an

18-26

anabolic steroid or human growth hormone for: (1) enhancing performance in an exercise, sport,

18-27

or game, or (2) hormonal manipulation intended to increase muscle mass, strength, or weight

18-28

without a medical necessity. Any person who violates this subsection is guilty of a misdemeanor

18-29

and upon conviction may be imprisoned for not more than six (6) months or a fine of not more

18-30

than one thousand dollars ($1,000), or both.

18-31

     (f) It is unlawful for any person to knowingly or intentionally possess, manufacture,

18-32

distribute, or possess with intent to manufacture or distribute any extract, compound, salt

18-33

derivative, or mixture of salvia divinorum or datura stramonium or its extracts, unless the person

18-34

is exempt pursuant to the provisions of section 21-28-3.30. Notwithstanding any laws to the

19-1

contrary, any person who violates this section is guilty of a misdemeanor, and, upon conviction,

19-2

may be imprisoned for not more than one year, or fined not more than one thousand dollars

19-3

($1,000), or both. The provisions of this section shall not apply to licensed physicians,

19-4

pharmacists, and accredited hospitals and teaching facilities engaged in the research or study of

19-5

salvia divinorum or datura stramonium, and shall not apply to any person participating in clinical

19-6

trials involving the use of salvia divinorum or datura stramonium.

19-7

     SECTION 3. This act shall take effect upon passage.

=======

LC00046/SUB A/2

========

EXPLANATION

BY THE LEGISLATIVE COUNCIL

OF

A N A C T

RELATING TO FOOD AND DRUGS - UNIFORM CONTROLLED SUBSTANCE ACT

***

20-1

     This act would add the hallucinogenic drugs Salvia Divinorum (Salvinorin A or

20-2

Divinorin A), Datura stramonmium (gypsum weed or jimsom weed) and synthetic cannabinoids

20-3

(synthetic marijuana) to the Rhode Island Controlled Substances Act Schedule 1, the misuse of

20-4

which may result in the requisite criminal penalties for abuse.

20-5

     This act would take effect upon passage.

=======

LC00046/SUB A/2

=======